XML 49 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity
6 Months Ended
Sep. 23, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders' Equity
Common Stock 

The Company issued a net 0.1 million shares of common stock for both the three and six months ended September 23, 2023, and 0.1 million for both the three and six months ended September 24, 2022, respectively, pursuant to the Company's equity incentive plans.

Share Repurchase Program 

In fiscal year 2024, the Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, included as a reduction to accumulated earnings (deficit) in the Consolidated Condensed Statements of Stockholders' Equity. Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes.

In January 2021, the Board of Directors authorized the repurchase of $350 million of the Company’s common stock. During the three months ended June 24, 2023, the Company completed share repurchases under the 2021 authorization, leaving
no remaining authorization under this program. In July 2022, the Board of Directors authorized the repurchase of up to $500 million of the Company's common stock. As of September 23, 2023, approximately $78.0 million of the Company's common stock has been repurchased under the 2022 share repurchase authorization, leaving approximately $422 million available for repurchase. During the three months ended September 23, 2023, the Company repurchased 0.5 million shares of the Company's common stock under the 2022 authorization for $40.6 million, at an average cost of $79.45 per share. During the six months ended September 23, 2023, the Company repurchased 1.0 million shares of the Company's common stock under the combined 2021 and 2022 authorizations for $79.1 million, at an average cost of $80.95 per share.